Dr. Cartagena, currently serving as CEO of NAPA, joined the organization in 2014 and has since driven significant clinical and operational advancements. As senior vice president for clinical services, he led an 87% increase in business unit growth, reduced the clinician vacancy rate from over 25% to an industry-leading 5%, and integrated American Anesthesiology into NAPA’s network, adding $1 billion in revenue and expanding operations across seven new states. Promoted to COO in 2020, he managed nearly $2 billion in revenue, implemented enterprisewide scheduling and revenue cycle systems, and launched NAPA’s first clinical leadership evaluation process. Since becoming CEO in 2023, Dr. Cartagena has championed fair insurer reimbursements with a 98% arbitration win rate and advanced technology initiatives to enhance revenue cycle management for healthcare partners. In addition to his leadership at NAPA, Dr. Cartagena serves on its board of directors and has held previous roles at Henrico Doctors Hospital in Richmond, Va., Total Anesthesia, and the University of North Carolina School of Medicine.
